Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Atkins

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.
Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2020
Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?Francine Heelan, Ranjeeta Mallick, Adam Bryant, et al.
European Journal of Haematology|January 6, 2025
Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (ATG) Based GVHD ProphylaxisVinita Dhir, Connor Prince, David Allan, et al.
European Journal of Haematology|July 9, 2024
Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantationHafsah Chalchal, Vinita Dhir, Ashish Masurekar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myelomaLaura Labonté, Tariq Iqbal, Mukarram A Zaidi, et al.
Transplantation and Cellular Therapy|February 14, 2026
Factors Associated with Prolonged Inpatient Stay in Patients undergoing Outpatient Allogeneic Stem Cell TransplantationEdward Koo, Connor Prince, David Allan, et al.
Journal of Law and the Biosciences|May 31, 2019
The stem cell market and policy options: a call for clarityAmy Zarzeczny, Harold Atkins, Judy Illes, et al.
Bone Marrow Transplantation|January 30, 2020
Total body irradiation (18 Gy) without chemotherapy as conditioning for allogeneic hematopoietic cell transplantation in refractory acute myeloid leukemiaSultan Altouri, David Allan, Harold Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2017
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell TransplantationAdam Bryant, Ranjeeta Mallick, Lothar Huebsch, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.
Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2020
Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?Francine Heelan, Ranjeeta Mallick, Adam Bryant, et al.
European Journal of Haematology|January 6, 2025
Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (ATG) Based GVHD ProphylaxisVinita Dhir, Connor Prince, David Allan, et al.
European Journal of Haematology|July 9, 2024
Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantationHafsah Chalchal, Vinita Dhir, Ashish Masurekar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myelomaLaura Labonté, Tariq Iqbal, Mukarram A Zaidi, et al.
Transplantation and Cellular Therapy|February 14, 2026
Factors Associated with Prolonged Inpatient Stay in Patients undergoing Outpatient Allogeneic Stem Cell TransplantationEdward Koo, Connor Prince, David Allan, et al.
Journal of Law and the Biosciences|May 31, 2019
The stem cell market and policy options: a call for clarityAmy Zarzeczny, Harold Atkins, Judy Illes, et al.
Bone Marrow Transplantation|January 30, 2020
Total body irradiation (18 Gy) without chemotherapy as conditioning for allogeneic hematopoietic cell transplantation in refractory acute myeloid leukemiaSultan Altouri, David Allan, Harold Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2017
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell TransplantationAdam Bryant, Ranjeeta Mallick, Lothar Huebsch, et al.
Pageof 8